Pozitivan test na fetalni fibronektin: rizik, vreme, sledeći koraci

Категорије
Чланци
Zdravlje u trudnoći Тумачење лабораторијских налаза Ажурирање за 2026. годину Прилагођено пацијентима

Pozitivan rezultat otvara pitanje rizika od prevremenog porođaja — ne odbrojava vreme do porođaja. Negativan rezultat je često korisniji, pod uslovom da uzorak i kliničke okolnosti odgovaraju testu.

📖 ~12 минута 📅
📝 Објављено: 🩺 Медицински прегледано: ✅ Засновано на доказима
⚡ Брзи резиме v1.0 —
  1. Pozitivan fFN obično znači da je fetalni fibronektin dostigao prag testa od približno 50 ng/mL; to ne potvrđuje porođaj niti predviđa datum porođaja.
  2. Negativan fFN može ukazivati na malu verovatnoću porođaja u roku od 7 dana kod odgovarajuće odabranih pacijentkinja sa simptomima, ali ne može nadjačati zabrinjavajuće simptome.
  3. Prediktivna vrednost zavisi od populacije: značajna studija kod simptomatskih pacijentkinja zabeležila je pozitivnu prediktivnu vrednost za 7 dana od 12.7% i negativnu prediktivnu vrednost od 99.5%.
  4. Gestacijska starost menja tumačenje; mnogi protokoli testiranja simptomatskih pacijentkinja koriste približno 24+0 do 34+6 nedelja, mada se kriterijumi podobnosti za test razlikuju.
  5. Dužina grlića materice pruža drugačije informacije od fFN; NICE u svom dijagnostičkom algoritmu za simptomatske pacijentkinje u 30. nedelji ili kasnije koristi prag od 15 mm.
  6. Nedavni seksualni odnos u roku od 24 sata može učiniti pozitivan rezultat manje pouzdanim; obavestite tim porodilišta pre uzimanja uzorka ili tumačenja rezultata.
  7. Uzimanje uzorka po pravilu treba obaviti pre digitalnog vaginalnog pregleda i drugih postupaka koji bi mogli da izmene uzorak, u skladu sa uputstvima za test.
  8. Потребна је хитна процена je potrebno u slučaju curenja plodove vode, krvarenja, redovnih bolnih kontrakcija ili smanjenih pokreta fetusa — čak i nakon negativnog rezultata.
  9. Одлуке о лечењу zavise od ukupne verovatnoće i vremena porođaja; pozitivan rezultat fFN testa sam po sebi ne zahteva automatski kortikosteroide, prijem u bolnicu ili mirovanje u krevetu.

Šta zapravo znači pozitivan rezultat fetalnog fibronektina?

A pozitivan rezultat testa na fetalni fibronektin znači da je brisom otkriven protein povezan sa interfejsom tkiva trudnoće, obično pri koncentraciji od približno 50 ng/mL ili više. To povećava zabrinutost zbog rizika od prevremenog porođaja, ali ne potvrđuje porođaj niti znači da će se vaša beba roditi u narednim danima.

Fetal fibronectin protein and extracellular matrix illustrated beside a pregnancy swab assay
Слика 1: Fetalni fibronektin ukazuje na promene na interfejsu tkiva, a ne na potvrđen datum porođaja.

Fetalni fibronektin, skraćeno fFN, jeste glikoprotein vanćelijskog matriksa koji se nalazi na interfejsu između plodovih ovojaka i majčinog tkiva. Prisustvo proteina koji se može detektovati sredinom trudnoće može biti praćeno narušavanjem tog interfejsa, ali rezultat iznad 50 ng/mL ne meri kontrakcije, otvaranje grlića materice niti spremnost bebe za porođaj.

Zamišljena pacijentkinja u 29. nedelji trudnoće mogla bi da ima osećaj stezanja, pozitivan nalaz brisa, očuvane plodove ovojke i bez promena na grliću materice tokom praćenja; kod druge pacijentkinje sa istim rezultatom moglo bi da dođe do progresivnog otvaranja grlića. To su različite kliničke situacije, zbog čega bih rezultat objasnio kao signal rizika, a ne kao dijagnozu.

Кантести је АИ анализатор крви, dok se fetalni fibronektin obično meri iz vaginalnog brisa, a ne iz uzorka krvi. Ja sam Thomas Klein, MD, glavni medicinski direktor kompanije Kantesti; ova razlika je važna jer granična vrednost od 50 ng/mL za bris pripada akušerskoj proceni, a ne rutinskom laboratorijskom panelu, kao što objašnjava naš organizaciona pozadina објашњава.

Kako funkcioniše fFN bris — i šta znači 50 ng/mL

Тхе test na fetalni fibronektin analizira vaginalni uzorak uzet tokom pregleda spekulumom; uobičajena kvalitativna granična vrednost je 50 ng/mL. Ta granična vrednost razdvaja kategorije testa, a ne bezbedne trudnoće od trudnoća kod kojih je prevremeni porođaj izvestan.

Fetal fibronectin collection swab, extraction container, and rapid immunoassay cartridge
Слика 2: Testom brisa meri se protein, a ne postavlja dijagnoza kontrakcija.

Kvalitativni fFN test daje pozitivan ili negativan rezultat, dok kvantitativno testiranje daje koncentraciju, ponekad koristeći kategorije rizika kao što su 10, 50, 200 i 500 ng/mL. Naš vodič za kvalitativno naspram kvantitativnog objašnjava razliku u izveštavanju, iako su u primerima uzorci krvi, a ne akušerski brisevi.

Koncentracija fFN od 55 ng/mL and one of 500 ng/mL can both appear as positive on a binary report, even though a quantitative pathway may assign different risk estimates. Ask whether the original report contains an actual concentration; the word positive may conceal information that the laboratory measured but the discharge summary omitted.

Boundary values need assay-specific reading: many qualitative assays classify 50 ng/mL or above as positive, whereas NICE describes 50 ng/mL or less as negative and more than 50 ng/mL as positive in its numerical pathway. NICE NG25 and the laboratory's reporting convention should therefore be read together rather than treating exactly 50 as universally classified.

Common qualitative negative category <50 ng/mL Supports a lower short-term delivery probability when the patient and sample meet assay eligibility.
Common qualitative positive category ≥50 ng/mL Raises risk concern but does not diagnose labor or establish imminent delivery.
NICE numerical boundary ≤50 versus >50 ng/mL NICE NG25 uses this numerical distinction when fFN is used in its specified diagnostic pathway.
Higher quantitative concentrations Examples: 200 or 500 ng/mL May increase estimated risk in validated quantitative models; there is no universal concentration that makes birth certain.

Zašto većina pozitivnih rezultata fFN ne predviđa porođaj u roku od nedelju dana

A positive fFN test has limited ability to predict delivery within 7 dana, because many symptomatic patients do not deliver during that period. In Peaceman et al.’s multicenter study, the 7-day positive predictive value was 12.7%.

Physical obstetric assessment sequence showing swab testing followed by clinical observation
Слика 3: A positive swab is one step in a wider assessment.

Pozitivna prediktivna vrednost describes how many patients with a positive result experience the outcome being predicted; it is not the percentage of all pregnancies that deliver prematurely. In Peaceman et al. (1997), approximately 13 of every 100 positive patients delivered within 7 days, so most positives did not indicate delivery that week.

Тхе starting probability changes the meaning of the same positive swab: a patient with previous spontaneous birth at 28 weeks, increasing contractions, and cervical change is not equivalent to someone with mild intermittent tightening and a closed cervix. The 12.7% study estimate is useful for explaining uncertainty, but I would not present it as either patient's personalized probability.

Positive does not always mean disease, and the interpretation depends on what the test detects: protein, antibody, genetic material, or another target. Our pregnancy antibody-screen explanation addresses a different pregnancy test; neither an antibody result nor fFN above 50 ng/mL can be interpreted solely from the word positive.

Šta test fetalnog fibronektina sa negativnim rezultatom može — a šta ne može — da vam kaže

A fetal fibronectin test negative result can help identify a low probability of birth within 7 dana in appropriately selected symptomatic patients. Peaceman et al. reported a 7-day negative predictive value of 99.5%, but that figure is not a lifetime guarantee for the pregnancy.

Pregnant patient reviewing a blank appointment card beside an obstetric swab transport kit
Слика 4: A reassuring result applies to a short interval, not the entire pregnancy.

Negative predictive value is conditional on who was tested and how the sample was collected; 99.5% does not apply automatically to every gestational age or complication. The landmark estimate came from a defined symptomatic population, so clinicians should not simply transfer it to ruptured membranes, advanced dilation, or a completely different testing indication.

A negative fFN result today may support discharge after a reassuring examination, but symptoms that restart 3 days later deserve a fresh assessment. The original swab did not examine tomorrow's cervix or predict a later membrane rupture; the discharge plan should explain which changes require a return rather than saying only that the test was normal.

Pregnancy alters laboratory interpretation in more than one way, including kidney-function results and the eligibility of obstetric prediction tests. Our pregnancy kidney-function guide illustrates why gestation-specific context matters; a negative fFN below 50 ng/mL still needs its own obstetric examination and safety instructions.

Zašto gestacijska starost menja značenje rezultata fFN

Gestacijska starost determines whether fFN testing is appropriate and what decisions its result can support. Many symptomatic protocols use approximately 24+0 to 34+6 weeks, but eligibility varies by assay and local maternity pathway.

Standing pregnant patient and clinician discussing gestational timing beside a swab collection kit
Слика 5: Gestational timing determines both test eligibility and the consequences of uncertainty.

Fetal fibronectin can be present physiologically earlier in pregnancy and closer to term, which limits interpretation outside the intended testing window. A positive result at 18 weeks should not be assigned the same 7-day predictive value as a correctly collected sample at 29 weeks; the assay's validated population is part of the result.

Before 30 weeks, NICE NG25 recommends treating clinically suspected preterm labor rather than relying on its later-gestation testing pathway to exclude it. At 30 weeks or later, the guideline offers cervical-length assessment and, when that is unavailable or unacceptable, fFN; the difference reflects the consequences of missing a very early birth, not a sudden biological change on one birthday.

A normal test cannot overrule an urgent presentation, especially when the test was used outside its intended population. Our normal-results and acute-pain guide explains this diagnostic principle in another setting; an fFN result below 50 ng/mL likewise cannot substitute for examination when pregnancy symptoms are concerning.

Kako dužina grlića materice menja tumačenje pozitivnog rezultata fFN

Transvaginal cervical length measures an anatomical feature that fFN does not: how much closed cervix remains. For symptomatic patients at 30 weeks or later, NICE uses 15 mm in its diagnostic pathway, while other protocols use different thresholds and combinations.

Watercolor illustration of obstetric ultrasound equipment used for cervical-length assessment
Слика 6: Ultrasound supplies anatomical information that a protein swab cannot provide.

A 35 mm cervix and a 12 mm cervix should not be treated as interchangeable findings merely because both patients have positive swabs. The shorter measurement usually increases concern, particularly with symptoms or cervical change; however, interpretation also depends on gestational age, measurement quality, and whether the clinician is diagnosing labor or estimating future risk.

NICE NG25 does not recommend combining cervical length and fFN to diagnose preterm labor in its specified pathway. Some services use combined risk assessment, particularly in intermediate cervical-length groups, but that is a different protocol; ask which pathway your unit follows rather than assuming a positive swab always cancels a reassuring measurement above 15 mm.

The 25 mm threshold often discussed in pregnancy relates to short-cervix screening and preventive decisions in particular earlier-gestation populations, not a universal diagnosis of symptomatic labor. Our progesterone reference guide explains another pregnancy measurement; do not start, stop, or increase progesterone because an fFN swab exceeds 50 ng/mL.

Koji simptomi su važniji od rezultata brisa?

Progressive cervical change, suspected membrane rupture, bleeding, and concerning maternal or fetal findings can outweigh a reassuring fFN result. A negative swab below 50 ng/mL does not make regular painful contractions or fluid leakage safe to manage without assessment.

Paired obstetric assessment layouts with swab kits and ultrasound equipment for clinical comparison
Слика 7: Similar swab results can accompany very different examination findings.

Contractions alone do not establish preterm labor, because tightening can occur without progressive cervical dilation; the assessment looks for the combination of symptoms and change. At 31 weeks, a patient whose contractions settle and whose examination remains unchanged differs from one whose cervix opens during observation, even if both swabs read positive.

Хипотетички 28-week pregnancy with fluid leakage illustrates the test's limit: the first question is whether membranes have ruptured, not whether an fFN concentration is below 50 ng/mL. When membrane rupture is suspected, clinicians use the appropriate history, examination, and testing pathway; an fFN result should not be repurposed as a membrane-rupture exclusion test.

Кантести је AI платформа за тумачење крвне слике, and an fFN swab at 50 ng/mL belongs to a clinical pathway our routine blood-analysis output cannot replace. Our клинички оквир за валидацију explains why a measured laboratory value and a validated obstetric triage decision are separate questions.

Šta uzrokuje lažno pozitivan rezultat fetalnog fibronektina?

A fetal fibronectin false positive can reflect collection interference or protein detected without delivery during the predicted interval. Recent intercourse within 24 сата, bleeding, and examination-related disturbance can make a positive result less straightforward to interpret.

Educational microscopic-style view of a swab tip and protein-containing sample material
Слика 8: Sample conditions influence whether a positive assay reflects useful risk information.

Analytical false positivity and prediction failure are different problems: an assay may genuinely detect fFN above 50 ng/mL while the patient does not deliver within 7 days. Calling every non-delivery a laboratory error misses the biology—the interface may have changed without progressing to labor, or the predicted outcome may simply not have occurred in that interval.

Collection order matters, so the swab is generally obtained before a digital vaginal examination and before other procedures that could affect the sample, following assay instructions. If an examination happened 20 minutes earlier, tell the team; that information may change confidence in a positive result without automatically proving that it is false.

Specimen quality belongs in the interpretation, not in a footnote added after treatment decisions. Our sample-interference explanation describes a different laboratory problem; fFN above 50 ng/mL has its own interference rules, and blood-sample advice should not be transferred directly to a vaginal swab.

Kako nedavni seksualni odnos i vaginalni preparati utiču na fFN

Intercourse within the previous 24 hours can reduce confidence in a positive fFN result, so disclose it before sampling. Vaginal products and recent procedures may also matter, but the laboratory's assay instructions determine whether collection should be delayed or the result qualified.

Fetal fibronectin antibody-binding illustration showing the importance of sample conditions
Слика 9: Assay instructions help separate detectable protein from collection-related interference.

A positive result after recent intercourse is not automatically evidence of imminent birth; the maternity team may regard that sample as unsuitable for confident positive interpretation. Some assay instructions allow a negative result to retain clinical usefulness despite intercourse within 24 hours, but this is not a blanket rule across every product and testing pathway.

Vaginal medication should not be stopped independently to obtain a cleaner swab, including prescribed progesterone used during pregnancy. Tell the clinician what was used and when—for example, a dose 8 hours before collection—so the unit can check its instructions; a delay in testing must never become a delay in assessing painful contractions or fluid leakage.

fFN is not an STI test, and positive fFN above 50 ng/mL does not diagnose chlamydia or another infection. Our chlamydia sampling and timing guide explains a separate assay, while bakterije bez urinarnih simptoma addresses another pregnancy-relevant question that requires its own specimen and treatment criteria.

Kada treba odmah da se obratite trijažnoj službi porodilišta?

Contact maternity triage promptly for regular painful contractions before 37 weeks, fluid leakage, vaginal bleeding, or reduced fetal movement. Seek assessment even if yesterday's fFN result was negative; a reassuring short-term prediction does not exclude a new complication.

Pregnant patient approaching modern maternity triage with a swab kit visible at the assessment station
Слика 10: New warning symptoms require assessment regardless of the previous swab result.

Do not wait for a contraction-count target if you suspect your waters have broken or your baby's movements have changed. A person at 30 weeks with repeated watery leakage needs maternity advice even without strong contractions; fFN testing is not a home decision tool, and a previous negative result should not postpone contact.

Severe headache, visual disturbance, upper abdominal pain, or sudden illness also deserve urgent pregnancy assessment because they may indicate conditions unrelated to fFN. Our HELLP warning-pattern guide explains one such emergency; a swab below 50 ng/mL offers no reassurance about blood pressure, platelets, or liver injury.

Different pregnancy symptoms need different tests: persistent itching, especially on palms or soles, may prompt bile-acid testing rather than another fFN swab. Our pregnancy bile-acid guide explains that distinction; tell triage your gestational age, the symptom onset time, and whether movement has changed in the past 24 hours.

Da li pozitivan rezultat fFN znači da su potrebni steroidi ili prijem u bolnicu?

A positive fFN result alone does not automatically require admission, corticosteroids, or medication to suppress contractions. Clinicians consider whether birth is genuinely likely within approximately 7 dana, the gestational age, cervical findings, membrane status, and access to appropriate neonatal care.

Brand-neutral obstetric ultrasound instrument beside a fetal fibronectin assay kit
Слика 11: Treatment decisions combine gestational timing, imaging, symptoms, and swab findings.

Antenatal corticosteroids help fetal maturation when early birth is sufficiently likely; they are not a treatment for fFN protein itself. NICE offers them at 24+0 to 33+6 weeks for relevant suspected or established preterm-birth situations and considers them at 34+0 to 35+6 weeks, with individualized discussion at earlier gestations; a positive swab must be interpreted within that clinical decision.

Tocolysis may buy time, commonly around 48 hours, for steroids or transfer when delaying birth is appropriate; it does not guarantee continuation to term. Magnesium sulfate for fetal neuroprotection has separate gestational and imminent-birth criteria, and antibiotics are not routinely indicated solely because fFN exceeds 50 ng/mL with intact membranes and no diagnosed infection.

Routine testing has not clearly improved every outcome, even though negative results can help risk assessment: Berghella and Saccone's Cochrane review (2019) found limited trial evidence for management guided by fFN results. I would therefore ask what decision the test changes in the next 24–48 hours; our medical-report safety checklist supports that distinction between interpreting a result and prescribing care.

Kako se analize krvi i urina dopunjuju sa fFN brisom

Blood and urine tests investigate different concerns from fFN, such as anemia, urinary infection, or maternal illness. A hemoglobin result in г/дл, a ferritin result in нг/мл, and an fFN swab concentration cannot be treated as interchangeable indicators of preterm labor.

Separate fetal fibronectin swab assembly and laboratory tube illustrating different specimen types
Слика 12: Different specimen types answer different questions during a pregnancy assessment.

Low iron stores do not explain away contractions, and a reassuring complete blood count does not exclude preterm labor. If ferritin is 12 ng/mL in a patient at 28 weeks, the clinician may address iron depletion while still assessing the contractions separately; our pregnancy ferritin guide explains the iron question rather than fFN risk.

Pregnancy can raise the white-cell count, so an isolated flagged count should not automatically be labeled infection or used to explain a positive fFN. Our pregnancy neutrophil reference guide discusses that context; the clinician still considers temperature, urinary symptoms, examination, and cultures, rather than using one count or a 50 ng/mL swab threshold as a diagnosis.

Iron-panel interpretation involves several related measurements, including ferritin and transferrin saturation, but none replaces cervical assessment. Our iron-studies interpretation guide explains those relationships; when reviewing a 3-part pregnancy workup—swab, blood panel, and urine specimen—keep each test linked to the question it was ordered to answer.

Šta treba da pitate pre nego što odete kući nakon testiranja fFN?

Before discharge, ask what your fFN result changes, whether the sample was valid, and which symptoms require immediate return. A plan should specify the short-term assessment interval—often framed around 7 dana—without implying that a negative result guarantees the rest of pregnancy.

Physical fFN follow-up pathway with swab kit, ultrasound probe, and blank appointment card
Слика 13: A useful discharge plan connects the result to clear return instructions.

Five practical questions are worth asking: What is my exact gestational age? Was my cervix measured or examined? Were my membranes intact? Could intercourse or a procedure affect the swab? What symptoms mean I should return immediately? A positive result above 50 ng/mL is much easier to understand when those answers are recorded alongside it.

Retesting is not a universal countdown schedule, and a second swab is useful only if it fits a validated pathway and can change management. If tightening restarts 4 days after a reassuring assessment, contact maternity triage rather than independently arranging another fFN test; examination, membrane assessment, or observation may be more useful than repeating the original measurement.

Кантести је Алат за анализу крвних тестова уз помоћ AI, not a substitute for examining a pregnant patient with new symptoms or interpreting a swab above 50 ng/mL in isolation. Our standardi medicinskog sadržaja describe the boundary between educational explanation and individualized care; routine bed rest is not automatically justified by a positive fFN and can introduce its own harms.

Dokazi, klinička procena i istraživačke publikacije

fFN interpretation rests on obstetric evidence, particularly the population tested, the prediction interval, and the clinical pathway. As of 21. oktobar 2026., this article distinguishes NICE NG25 recommendations from the 1997 predictive study and the 2019 Cochrane review rather than inventing a new universal cutoff.

Fetal fibronectin rapid assay and protein model arranged for evidence-focused medical education
Слика 14: Obstetric evidence supports risk interpretation, not certainty from one protein result.

Prediction and better outcomes are separate claims: Peaceman et al. reported 7-day predictive values, while Berghella and Saccone evaluated whether knowing fFN results improved management outcomes. NICE NG25 supplies a clinical pathway, not a promise that every positive above 50 ng/mL requires identical treatment; these sources should not be collapsed into one accuracy percentage.

Medical review should examine the whole decision, including gestation, symptoms, cervical findings, and sample validity—not just the 50 ng/mL threshold. My editorial emphasis as Thomas Klein, MD, is that understandable uncertainty is safer than false certainty; our медицински саветодавни одбор describes the expertise behind medical oversight, without this draft asserting a named individual's completed review.

The 2 supplied Kantesti repository publications concern blood-test interpretation and hematology, not prospective validation of fFN prediction or treatment decisions. They are listed below as research resources with DOI links and publication-search links; our resurs za tumačenje RDW covers red-cell measurements, which cannot establish the meaning of an obstetric swab or predict delivery within 7 days.

Често постављана питања

Da li pozitivan test na fetalni fibronektin znači da ću se poroditi pre termina?

Pozitivan test na fetalni fibronektin ne potvrđuje da ćete se poroditi ranije ili u narednih 7 dana. Obično znači da je brisom otkriven fFN u količini koja dostiže pozitivan prag testa, najčešće približno 50 ng/mL. U jednoj ključnoj studiji simptomatskih pacijentkinja, pozitivna prediktivna vrednost za porođaj u roku od 7 dana iznosila je 12.7%, tako da se većina pacijentkinja s pozitivnim rezultatom nije porodila te nedelje. Vaša gestacijska dob, simptomi, nalaz na grliću materice, stanje plodovih ovojaka i validnost uzorka određuju šta će se dalje dešavati.

Koliko je umirujući negativan test na fetalni fibronektin?

Negativan test na fetalni fibronektin može ukazivati na malu verovatnoću porođaja u roku od 7 dana kod odgovarajuće odabrane simptomatske pacijentkinje. Peaceman i sar. naveli su negativnu prediktivnu vrednost za 7 dana od 99.5%, ali ta procena se odnosi samo na populaciju i okolnosti obuhvaćene studijom. Negativan rezultat ne garantuje da će porođaj nastupiti u terminu niti isključuje nove komplikacije. Bez obzira na prethodni rezultat, obratite se trijažnoj službi porodilišta ako dođe do curenja plodove vode, krvarenja, redovnih bolnih kontrakcija ili smanjenih pokreta ploda.

Može li seksualni odnos izazvati lažno pozitivan fFN test?

Seksualni odnos u prethodna 24 sata može smanjiti pouzdanost pozitivnog rezultata testa na fetalni fibronektin. Obavestite tim porodilišta pre uzimanja brisa ili nakon toga ako shvatite da bi vreme odnosa moglo biti važno. Prema uputstvima za neke testove, negativan rezultat može i dalje biti koristan u ovoj situaciji, ali to zavisi od konkretnog testa i protokola. Nemojte odlagati hitnu procenu simptoma u trudnoći samo da biste sačekali da protekne period potreban za testiranje.

Šta znači pozitivan fFN test uz normalnu dužinu grlića materice?

0 Pozitivan fFN test uz zadovoljavajuću dužinu grlića materice može biti manje zabrinjavajući nego isti rezultat brisa uz izrazito skraćen grlić materice, ali tumačenje zavisi od protokola. Merenje od 35 mm i merenje od 12 mm pružaju različite anatomske informacije. NICE koristi prag od 15 mm u svom protokolu za simptomatske pacijentkinje u 30. nedelji trudnoće ili kasnije i ne preporučuje kombinovanje dužine grlića materice i fFN testa za dijagnostikovanje prevremenog porođaja u tom protokolu. Druge ustanove mogu koristiti kombinovane modele rizika, pa pitajte koji protokol usmerava vašu negu.

Da li pozitivan fFN test znači da su mi potrebne injekcije steroida?

Pozitivan fFN test sam po sebi ne znači automatski da su vam potrebni antenatalni kortikosteroidi. Lekari procenjuju da li je dovoljno verovatno da će doći do prevremenog porođaja u narednih približno 7 dana i da li je lečenje odgovarajuće za vašu gestacijsku dob i okolnosti. NICE preporučuje kortikosteroide od 24+0 do 33+6 nedelja u relevantnim situacijama kada se sumnja na prevremeni porođaj ili je on potvrđen, a razmatra ih od 34+0 do 35+6 nedelja. Promene na grliću materice, stanje plodovih ovoja, drugi nalazi i prethodno lečenje su važni.

Da li je fetalni fibronektin analiza krvi i može li se koristiti nakon pucanja vodenjaka?

Fetalni fibronektin se obično meri iz vaginalnog brisa, a ne iz uzorka krvi. Mnogi testovi za simptomatske pacijentkinje namenjeni su onima sa očuvanim plodovim ovojcima, u definisanom gestacijskom periodu, često približno od 24+0 do 34+6 nedelja. Ako je moguće da je došlo do prsnuća vodenjaka, obratite se trijažnoj službi porodilišta radi odgovarajuće procene prsnuća plodovih ovojaka, umesto da se oslanjate na rezultat fFN testa. Negativan rezultat brisa, ispod 50 ng/mL, ne može pouzdano isključiti prsnuće plodovih ovojaka.

Укључите AI анализу крвне слике данас

Придружите се више од 2 милиона корисника широм света који верују Kantesti-у за тренутну и прецизну анализу лабораторијских тестова. Отпремите своје резултате крвне слике и добијте свеобухватно тумачење 15,000+ биомаркера за неколико секунди.

📚 Референциране научне публикације

1

Klajn, T., Mičel, S., i Veber, H. (2026). AI анализа крвне слике: анализирано 2,5M тестова | Глобални здравствени извештај 2026. Kantesti AI Medical Research.

2

Klajn, T., Mičel, S., i Veber, H. (2026). RDW тест крви: Комплетан водич за RDW-CV, MCV и MCHC. Kantesti AI Medical Research.

📖 Спољне медицинске референце

3

National Institute for Health and Care Excellence (2015; updated 2022). Preterm labour and birth: NICE guideline NG25. CE.

4

Peaceman AM et al. (1997). Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. American Journal of Obstetrics and Gynecology.

5

Berghella V, Saccone G (2019). Fetal fibronectin testing for reducing the risk of preterm birth. Кокрејн база података систематских прегледа.

2 милиона+Анализирани тестови
127+Земље
75+Језици

⚕️ Медицинска одрицање одговорности

Е-Е-А-Т сигнали поверења

⭐

Искуство

Клиничка ревизија процеса тумачења лабораторијских налаза коју води лекар.

📋

Експертиза

Фокус на лабораторијску медицину: како се биомаркери понашају у клиничком контексту.

👤

Ауторитативност

Написао др Томас Клајн, уз рецензију др Саре Мичел и проф. др Ханса Вебера.

🛡️

Поузданост

Тумачење засновано на доказима, са јасним путевима праћења како би се смањила узнемиреност.

🏢 Кантести Д.О.О. Регистровaно у Енглеској и Велсу · Број компаније. 17090423 Лондон, Уједињено Краљевство · кантести.нет
blank
Од стране Prof. Dr. Thomas Klein

Др Томас Клајн је сертификовани клинички хематолог који обавља функцију главног медицинског службеника (Chief Medical Officer) у Kantesti AI. Са више од 15 година искуства у лабораторијској медицини и снажним интересовањем за тумачење резултата крвне слике уз подршку вештачке интелигенције, ради на повезивању нове технологије са свакодневном клиничком праксом. Његове области интересовања укључују анализу биомаркера, истраживање клиничке подршке одлучивању и оптимизацију референтних опсега специфичних за популацију. Као CMO, он даје клинички допринос интерном бенчмаркингу платформе и пружа клинички надзор над медицинским квалитетом едукативних извештаја компаније Kantesti.

Оставите одговор

Ваша адреса е-поште неће бити објављена. Неопходна поља су означена *